Cargando…

Management of Hepatitis A-induced Macrophage Activation Syndrome With Anakinra in Systemic Juvenile Idiopathic Arthritis: A Case Report

Macrophage activation syndrome (MAS) is a severe and life-threatening complication of rheumatic diseases in childhood. It is most associated with systemic juvenile idiopathic arthritis (sJIA). We present the case of a nine-year-old boy diagnosed with sJIA for six years who developed MAS triggered by...

Descripción completa

Detalles Bibliográficos
Autores principales:	AlNouwaiser, Deena N, AlMutairi, Sajdi S, AlRowailey, Abdullah S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769770/ https://www.ncbi.nlm.nih.gov/pubmed/35103223 http://dx.doi.org/10.7759/cureus.21430

Ejemplares similares

Acquired Saccular Abdominal Aortic Aneurysm in a 10-Year-Old Child: A Case Report and Literature Review
por: Alfayez, Adel A, et al.
Publicado: (2023)

Isolated Facet Joint Arthritis in Juvenile Idiopathic Arthritis
por: Martone, Giulia, et al.
Publicado: (2021)

JAK inhibitors in systemic juvenile idiopathic arthritis
por: He, Tingyan, et al.
Publicado: (2023)

Systemic juvenile idiopathic arthritis: The Great Ormond Street Hospital experience (2005–2021)
por: Foley, C. M., et al.
Publicado: (2023)

Standard and increased canakinumab dosing to quiet macrophage activation syndrome in children with systemic juvenile idiopathic arthritis
por: Kostik, Mikhail M., et al.
Publicado: (2022)

Anakinra treatment in patients with systemic-onset juvenil idiopathic arthritis: “The Valencia Experience”
por: Marvillet, I, et al.
Publicado: (2011)

Wilson’s Disease Masquerading as Juvenile Idiopathic Arthritis in an Adolescent
por: Goyal, Rajeev, et al.
Publicado: (2020)

A Study Protocol for the Management of Children With Juvenile Idiopathic Arthritis Based on ePROs
por: Shen, Biyu, et al.
Publicado: (2022)

Application of Intra-articular Corticosteroid Injection in Juvenile Idiopathic Arthritis
por: Li, Sha, et al.
Publicado: (2022)

Anakinra in systemic juvenile idiopathic arthritis (soJIA) non responsive to antiTNF
por: Pontikaki, I, et al.
Publicado: (2008)

Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes
por: Urien, Saik, et al.
Publicado: (2013)

An Economic Comparison of Treatment Strategies with Anakinra in Systemic Juvenile Idiopathic Arthritis (sJIA)
por: Bullement, Ash, et al.
Publicado: (2021)

The Importance of Differentiating Oligoarticular Juvenile Idiopathic Arthritis From Lyme Arthritis in Pediatric Patients
por: Jeelani, Wajiha, et al.
Publicado: (2022)

Case report: Durable response to ruxolitinib in a child with TREX1-related disorder
por: Bin Khathlan, Yasir, et al.
Publicado: (2023)

Long-term follow-up of systemic onset juvenile idiopathic arthritis patients treated with Anakinra
por: Gattorno, Marco, et al.
Publicado: (2011)

Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2019)

Kawasaki Disease and Systemic Juvenile Idiopathic Arthritis – Two Ends of the Same Spectrum
por: Go, Ellen, et al.
Publicado: (2021)

Value of Literature Review to Inform Development and Use of Biologics in Juvenile Idiopathic Arthritis
por: Golhen, Klervi, et al.
Publicado: (2022)

Identification of novel autoantigens as potential biomarkers in juvenile idiopathic arthritis associated uveitis
por: Arve-Butler, Sabine, et al.
Publicado: (2023)

Epidemiology and demographics of juvenile idiopathic arthritis in Africa and Middle East
por: Al-Mayouf, Sulaiman M., et al.
Publicado: (2021)

The Biologic Basis of Clinical Heterogeneity in Juvenile Idiopathic Arthritis
por: Eng, Simon W M, et al.
Publicado: (2014)

Prolonged Fever in a Pediatric Patient: A Case of Systemic Juvenile Idiopathic Arthritis (sJIA) Complicated by Macrophage Activation Syndrome (MAS)
por: Cortes, Marianne, et al.
Publicado: (2023)

Risk Factors and Biomarkers for the Occurrence of Uveitis in Juvenile Idiopathic Arthritis: Data From the Inception Cohort of Newly Diagnosed Patients With Juvenile Idiopathic Arthritis Study
por: Tappeiner, Christoph, et al.
Publicado: (2018)

Comparing Proxy, Adolescent, and Adult Assessments of Functional Ability in Adolescents With Juvenile Idiopathic Arthritis
por: Shoop‐Worrall, Stephanie J. W., et al.
Publicado: (2020)

Predictive Value of Magnetic Resonance Imaging in Patients With Juvenile Idiopathic Arthritis in Clinical Remission
por: Mazzoni, Marta, et al.
Publicado: (2022)

Anakinra for systemic onset juvenile idiopathic arthritis: experience as a second versus first line treatment
por: Ricart, S, et al.
Publicado: (2011)

Quantifying Temporomandibular Joint Synovitis in Children With Juvenile Idiopathic Arthritis
por: Resnick, Cory M., et al.
Publicado: (2016)

Overlapping Features in Kawasaki Disease-Related Arthritis and Systemic-Onset Juvenile Idiopathic Arthritis: A Nationwide Study in Japan
por: Kanemasa, Hikaru, et al.
Publicado: (2021)

Epidemiology of juvenile idiopathic arthritis in Oman
por: Abdwani, Reem, et al.
Publicado: (2015)

Association of Anxiety With Pain and Disability but Not With Increased Measures of Inflammation in Adolescent Patients With Juvenile Idiopathic Arthritis
por: Hanns, Laura, et al.
Publicado: (2020)

Uveitis Is a Risk Factor for Juvenile Idiopathic Arthritis' Significant Flare in Patients Treated With Biologics
por: Kostik, Mikhail M., et al.
Publicado: (2022)

Costs of Hospital‐Associated Care for Patients With Juvenile Idiopathic Arthritis in the Dutch Health Care System
por: Kip, Michelle M. A., et al.
Publicado: (2022)

Case report: Emapalumab for active disease control prior to hematopoietic stem cell transplantation in refractory systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome
por: Chellapandian, Deepak, et al.
Publicado: (2023)

Tumefactive synovial thickening mimicking synovial chondromatosis in the setting of oligoarticular juvenile idiopathic arthritis in a toddler
por: Rousslang, Lee K., et al.
Publicado: (2019)

Tocilizumab in Systemic Juvenile Idiopathic Arthritis: Response Differs by Disease Duration at Medication Initiation and by Phenotype of Disease
por: Yan, Xin, et al.
Publicado: (2021)

Validity and Reliability of Four Parent/Patient–Reported Outcome Measures for Juvenile Idiopathic Arthritis Remote Monitoring
por: van Dijkhuizen, E. H. Pieter, et al.
Publicado: (2022)

Case Report: Life-Threatening Macrophage Activation Syndrome With Fulminant Myocarditis Successfully Rescued by High Dose Intravenous Anakinra
por: Meneghel, Alessandra, et al.
Publicado: (2021)

Persistent Tenosynovitis, Steroid Dependency and a Hyperpigmented Scaly Macular Rash in a Child With Juvenile Idiopathic Arthritis
por: Papatesta, Eleni Maria, et al.
Publicado: (2020)

Multicentric Carpo-Tarsal Osteolysis Syndrome Mimicking Juvenile Idiopathic Arthritis: Two Case Reports and Review of the Literature
por: Wu, Junfeng, et al.
Publicado: (2021)

Hip Involvement in Juvenile Idiopathic Arthritis: A Roadmap From Arthritis to Total Hip Arthroplasty or How Can We Prevent Hip Damage?
por: Sorokina, Lubov S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_va2k41pvomi622rg8vk1fgmv74